Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology
暂无分享,去创建一个
[1] S. Ozanne. Epigenetics and metabolism in 2014: Metabolic programming—knowns, unknowns and possibilities , 2015, Nature Reviews Endocrinology.
[2] M. Morris,et al. Transformations and invariance in the sensitivity analysis of computer experiments , 2014 .
[3] Yoram Vodovotz,et al. Global sensitivity analysis of a mathematical model of acute inflammation identifies nonlinear dependence of cumulative tissue damage on host interleukin-6 responses. , 2014, Journal of theoretical biology.
[4] Y. Cheng,et al. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression , 2014, Oncogene.
[5] Paolo Valigi,et al. An approach to the conditional robustness problem for biochemical networks , 2014, 2014 American Control Conference.
[6] R. Herbst,et al. A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non–Small Cell Lung Cancer , 2014, Clinical Cancer Research.
[7] L. Brim,et al. Robustness Analysis of Stochastic Biochemical Systems , 2014, PloS one.
[8] Ka-Lok Ng,et al. In silico identification of potential targets and drugs for non-small cell lung cancer. , 2014, IET systems biology.
[9] Prahlad T. Ram,et al. Cancer Systems Biology: a peek into the future of patient care? , 2014, Nature Reviews Clinical Oncology.
[10] G. Lopes,et al. Biomarkers and Receptor Targeted Therapies Reduce Clinical Trial Risk in Non–Small-Cell Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[11] M. Karamouzis,et al. Tackling the cancer signal transduction “Labyrinth”: A combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defect , 2014, Cancer.
[12] Tim Geach. Basic research: Antifungal treatment for glioma? , 2014, Nature Reviews Clinical Oncology.
[13] Laura E. Edwards,et al. Supplementary Figure Legends , 2022 .
[14] M. Ellis,et al. Incorporating Genomics into Breast Cancer Clinical Trials and Care , 2013, Clinical Cancer Research.
[15] Joshua C. Gilbert,et al. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.
[16] John J. Tyson,et al. Optimization and model reduction in the high dimensional parameter space of a budding yeast cell cycle model , 2013, BMC Systems Biology.
[17] The Cancer Genome Atlas Research Network. COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.
[18] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[19] Paolo Valigi,et al. Robustness of complex feedback systems: application to oncological biochemical networks , 2013, Int. J. Control.
[20] Francesco Amato,et al. Validation of a model of the GAL regulatory system via robustness analysis of its bistability characteristics , 2013, BMC Systems Biology.
[21] John G. Albeck,et al. Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. , 2013, Molecular cell.
[22] Gunnar Cedersund,et al. Conclusions via unique predictions obtained despite unidentifiability – new definitions and a general method , 2012, The FEBS journal.
[23] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[24] Igor Goryanin,et al. Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 network , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] Julio R. Banga,et al. Novel global sensitivity analysis methodology accounting for the crucial role of the distribution of input parameters: application to systems biology models , 2012 .
[26] W. D. den Dunnen,et al. Optimizing targeted cancer therapy: towards clinical application of systems biology approaches. , 2012, Critical reviews in oncology/hematology.
[27] William Becker,et al. A comparison of two sampling methods for global sensitivity analysis , 2012, Comput. Phys. Commun..
[28] Razelle Kurzrock,et al. PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] G. Mills,et al. Future of personalized medicine in oncology: a systems biology approach. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Ahmad S. Khalil,et al. Synthetic biology: applications come of age , 2010, Nature Reviews Genetics.
[31] G. Venter,et al. An algorithm for fast optimal Latin hypercube design of experiments , 2010 .
[32] Mustafa Khammash,et al. Parameter Estimation and Model Selection in Computational Biology , 2010, PLoS Comput. Biol..
[33] Heinz Koeppl,et al. ‘Glocal’ Robustness Analysis and Model Discrimination for Circadian Oscillators , 2009, PLoS Comput. Biol..
[34] Eduardo Sontag,et al. Geometry and topology of parameter space: investigating measures of robustness in regulatory networks , 2009, Journal of mathematical biology.
[35] François Fages,et al. A general computational method for robustness analysis with applications to synthetic gene networks , 2009, Bioinform..
[36] L. Crinò,et al. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[37] Eduardo D. Sontag,et al. Shape, Size, and Robustness: Feasible Regions in the Parameter Space of Biochemical Networks , 2007, PLoS Comput. Biol..
[38] H. Kitano. Towards a theory of biological robustness , 2007, Molecular systems biology.
[39] U. Alon. Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.
[40] Emanuele Borgonovo,et al. A new uncertainty importance measure , 2007, Reliab. Eng. Syst. Saf..
[41] H. Kitano. A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.
[42] Vipul Periwal,et al. System Modeling in Cellular Biology: From Concepts to Nuts and Bolts , 2006 .
[43] S. Basu,et al. Spatiotemporal control of gene expression with pulse-generating networks. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Doyle,et al. Robustness as a measure of plausibility in models of biochemical networks. , 2002, Journal of theoretical biology.
[45] G. Odell,et al. The segment polarity network is a robust developmental module , 2000, Nature.
[46] M. Elowitz,et al. A synthetic oscillatory network of transcriptional regulators , 2000, Nature.
[47] J. Collins,et al. Construction of a genetic toggle switch in Escherichia coli , 2000, Nature.
[48] Jenq-Neng Hwang,et al. Nonparametric multivariate density estimation: a comparative study , 1994, IEEE Trans. Signal Process..
[49] Paolo Valigi,et al. Computational model of EGFR and IGF1R pathways in lung cancer: a Systems Biology approach for Translational Oncology. , 2012, Biotechnology advances.
[50] Paolo Valigi,et al. Dynamic Modeling and Parameter Identification for Biological Networks: Application to the DNA Damage and Repair Processes , 2011, Handbook of Research on Computational and Systems Biology.
[51] A. Poustka,et al. Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance , 2009 .
[52] Kwang-Hyun Cho,et al. Quantitative analysis of robustness and fragility in biological networks based on feedback dynamics , 2008 .
[53] S. Sheather. Density Estimation , 2004 .
[54] N. Glick. Measurements of separation among probability densities or random variables , 1975 .
[55] Article number: 2006.0028 REVIEW Synthetic biology: new engineering rules for , 2022 .